MediciNova
MNOV
51 hedge funds and large institutions have $64.6M invested in MediciNova in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
4% more funds holding
Funds holding: 49 → 51 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.63% less ownership
Funds ownership: 22.51% → 21.88% (-0.63%)
17% less capital invested
Capital invested by funds: $77.9M → $64.6M (-$13.3M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $121K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$852K |
| 2 |
Millennium Management
New York
|
+$729K |
| 3 |
Morgan Stanley
New York
|
+$338K |
| 4 |
Renaissance Technologies
New York
|
+$274K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$208K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.82M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.02M |
| 3 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$399K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$346K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$276K |
MNOV Hedge Fund Activity: Q4 2019 in Review
51 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2019, worth a combined $64.6M — down 17% from $77.9M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MNOV positions and 6 closed out — a net gain of 2 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $852K. The largest seller was BlackRock, cutting an estimated $2.82M.
- 51 institutional investors held MediciNova (MNOV) as of Q4 2019, up from 49 in Q3 2019.
- Funds reported $64.6M of MediciNova stock for Q4 2019, down 17% quarter-over-quarter.
- 8 funds opened new MediciNova positions in Q4 2019 and 6 closed out, a net change of +2 holders.
- The largest MediciNova buyer in Q4 2019 was Vanguard Group, an estimated $852K added.
- The largest MediciNova seller in Q4 2019 was BlackRock, an estimated $2.82M sold.
Based on aggregated 13F filings for Q4 2019.